Literature DB >> 8578634

Glomerular ultrastructural lesions of idiopathic cutaneous and renal glomerular vasculopathy of greyhounds.

D M Hertzke1, L A Cowan, P Schoning, B W Fenwick.   

Abstract

Idiopathic cutaneous and renal glomerular vasculopathy (CRGV) (Alabama rot) is a potentially fatal disease of unknown etiology that affects the skin and kidneys of racing- and training-age Greyhounds. Ultrastructural examinations were performed on two healthy control Greyhounds and 12 Greyhounds diagnosed with CRGV based on the presence of characteristic, well-demarcated cutaneous ulcers of the extremities (12/12), thrombocytopenia (< 200,000 platelets/dl) (12/12), and acute renal insufficiency (BUN > 40 mg/dl, serum creatinine > 2.0 mg/dl) (7/12). Early glomerular ultrastructural changes included endothelial swelling, detachment, and necrosis; membranous whorl formation; and platelet adhesion and aggregation. Some capillaries were occluded with aggregated platelets, cellular fragments, and fibrin. Later changes included narrowing of capillary lumina and thickening of glomerular capillary walls by subendothelial accumulation of flocculent, amorphous, variable electron-dense material and occasionally erythrocytes, cellular processes, and fibrin. Glomerular endothelial cells were increased in number and plump, with villouslike cytoplasmic projections. Mesangial cell cytoplasmic processes occasionally were interposed between the endothelium and the basement membrane. No etiologic agents or electron-dense deposits typical of immune complexes were observed. Although the specific etiology was not determined, the ultrastructural changes suggest that glomerular endothelial damage is an important early event in the pathogenesis of CRGV.

Entities:  

Mesh:

Year:  1995        PMID: 8578634     DOI: 10.1177/030098589503200501

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  12 in total

1.  Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits.

Authors:  D J Bast; J L Brunton; M A Karmali; S E Richardson
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

Review 2.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

3.  Shiga-like toxin II derived from Escherichia coli O157:H7 modifies renal handling of levofloxacin in rats.

Authors:  Ying Lan Zhao; Xiao Bo Cen; Masafumi Ito; Keiko Yokoyama; Kenji Takagi; Kiyoyuki Kitaichi; Masayuki Nadai; Michio Ohta; Kenzo Takagi; Takaaki Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

Review 4.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7.

Authors:  Carla Calderon Toledo; Trisha Jayne Rogers; Majlis Svensson; Ramesh Tati; Hans Fischer; Catharina Svanborg; Diana Karpman
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

Review 6.  Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy.

Authors:  Lindsay Keir; Richard J M Coward
Journal:  Pediatr Nephrol       Date:  2010-10-15       Impact factor: 3.714

7.  Cutaneous and renal glomerular vasculopathy as a cause of acute kidney injury in dogs in the UK.

Authors:  L P Holm; I Hawkins; C Robin; R J Newton; R Jepson; G Stanzani; L A McMahon; P Pesavento; T Carr; T Cogan; C G Couto; R Cianciolo; D J Walker
Journal:  Vet Rec       Date:  2015-03-23       Impact factor: 2.695

8.  Virulence Genes, Shiga Toxin Subtypes, Serogroups, and Clonal Relationship of Shiga Toxin-Producing Escherichia Coli Strains Isolated from Livestock and Companion Animals.

Authors:  Nicolás Galarce; Beatriz Escobar; Fernando Sánchez; Esteban Paredes-Osses; Raúl Alegría-Morán; Consuelo Borie
Journal:  Animals (Basel)       Date:  2019-09-27       Impact factor: 2.752

9.  Plasma Vasoprotective Eicosanoid Concentrations in Healthy Greyhounds and Non-Greyhound Dogs.

Authors:  J T Martinez; L K Rogers; C Kellogg; M C Iazbik; C G Couto; B M Pressler; T M Hoepf; M J Radin
Journal:  J Vet Intern Med       Date:  2016-01-24       Impact factor: 3.333

10.  Description of the Use of Plasma Exchange in Dogs With Cutaneous and Renal Glomerular Vasculopathy.

Authors:  Ragnhild Skulberg; Stefano Cortellini; Daniel L Chan; Giacomo Stanzani; Rosanne E Jepson
Journal:  Front Vet Sci       Date:  2018-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.